Technical Analysis for AVGR - Avinger, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.78 | 0.00% | 0.00 |
Earnings due: Nov 7
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Gapped Up | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Narrow Range Bar | Range Contraction | -6.02% | |
Wide Bands | Range Expansion | -6.02% | |
NR7 | Range Contraction | -6.04% | |
Narrow Range Bar | Range Contraction | -6.04% |
Alert | Time |
---|---|
Gap Up Closed | about 19 hours ago |
Gap Up Partially Closed | about 19 hours ago |
Gapped Up (Partial) | about 22 hours ago |
Up 3% | about 22 hours ago |
Fell Below Lower Bollinger Band | about 22 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 11/07/2024
Avinger, Inc. Description
Avinger, Inc., a medical device company, designs, manufactures, and sells image-guided, catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD). It offers Lightbox, an imaging console, which enables the use of lumivascular catheters during PAD procedures; Ocelot, a chronic total occlusion (CTO) crossing catheter, which allows physicians to see the inside of an artery during a CTO crossing procedure; Ocelot PIXL, a lower profile CTO-crossing device for below-the-knee arteries; and Ocelot MVRX, a device which offers a tip design for above-the-knee arteries. The company also provides Wildcat, a catheter that facilitates the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention; and Kittycat 2, a catheter that facilitate the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists directly in the United States and Europe. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Imaging Catheter Medical Imaging Interventional Radiology Knee Artery Cordis Interventional Cardiology Percutaneous Peripheral Arterial Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.45 |
52 Week Low | 0.76 |
Average Volume | 276,004 |
200-Day Moving Average | 2.24 |
50-Day Moving Average | 1.00 |
20-Day Moving Average | 0.87 |
10-Day Moving Average | 0.84 |
Average True Range | 0.08 |
RSI (14) | 35.90 |
ADX | 14.96 |
+DI | 18.43 |
-DI | 25.28 |
Chandelier Exit (Long, 3 ATRs) | 1.09 |
Chandelier Exit (Short, 3 ATRs) | 1.00 |
Upper Bollinger Bands | 0.98 |
Lower Bollinger Band | 0.77 |
Percent B (%b) | 0.07 |
BandWidth | 25.00 |
MACD Line | -0.06 |
MACD Signal Line | -0.06 |
MACD Histogram | -0.0043 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.84 | ||||
Resistance 3 (R3) | 0.84 | 0.83 | 0.83 | ||
Resistance 2 (R2) | 0.83 | 0.81 | 0.82 | 0.83 | |
Resistance 1 (R1) | 0.80 | 0.80 | 0.80 | 0.80 | 0.82 |
Pivot Point | 0.79 | 0.79 | 0.78 | 0.79 | 0.79 |
Support 1 (S1) | 0.76 | 0.77 | 0.76 | 0.76 | 0.74 |
Support 2 (S2) | 0.75 | 0.76 | 0.75 | 0.73 | |
Support 3 (S3) | 0.72 | 0.75 | 0.73 | ||
Support 4 (S4) | 0.72 |